Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 13855

Miami, FL 33174

Study Summary:

Randomized, double-blind, stratified, parallel-group, multicenter study, 26 weeks in duration, that is designed to evaluate the non-inferiority of fluticasone propionate/salmeterol combination versus fluticasone propionate on the composite endpoint of serious asthma outcomes (asthma-related hospitalization, endotrachealintubation, and death) in subjects with asthma.

Qualified Participants Must:

• Be 12 years of age and older
• Be appropriately using treatment for asthma
• Be diagnosed with asthma for at least 1 year prior to study enrolment
• Have the ability to answer questions regarding asthma status and quality of life and ability to use a daily electronic data capture system
• Have the ability to demonstrate proper use of a metered-dose inhaler and dry powder inhaler (DPI) device

Qualified Participants May Receive:

All patient care and medications related to the study(No placebo medication will be provide). Compensation for time and travel for those who qualified.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.